Dr James Matera explains the impact of hypertension, chronic kidney disease, and end-stage renal disease on cardiometabolic risk — topics he discussed in his presentation, "Addressing Your Patient's...
What have practitioners learned from the first wave of COVID-19 that can be applied to the treatment of patients with autoimmune rheumatic conditions during this next wave? Michael George, MD, discusses in...